Formulation Development and Innovation: EPM
February 24, 2021
The global market for topical pharmaceuticals is forecasted to increase by $70 billion USD over the next 4-5 years although due to these dosage forms being difficult to develop the industry is increasingly turning to automation in order to mitigate the risk of a product failure during formulation development.
In this article with European Pharmaceutical Manufacturer, Professor Marc Brown, Dr. Jon Lenn and Dr. Charles Evans, discuss the latest industry innovations, the benefits of automation and mitigating the risk of product failure in topical drug development.
Read the full article here.
MedPharm is the world’s leading contract provider of topical and transdermal product design and formulation development services. MedPharm is experts at reducing risk and accelerating development times for generic and proprietary pharmaceutical customers through their unique, cost-effective and industry-leading performance testing models. Well established as the global leaders in dermatology, nail, mucosal membrane, and transdermal product development, MedPharm can also offer innovative solutions for ophthalmic and airway preparations recognised for their scientific rigour by regulators and investors. MedPharm has fully established Centers of Excellence in the USA and the UK.